Cancer Research UK

Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer

10 June 2024

Tackling cancer is a major global priority. Early detection and diagnosis can help patients get timely access to treatment and dramatically improve cancer outcomes. This relies, in part, on the effective diagnostic tests.

Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations

1 December 2021

Outcome-based payment (OBP) is a flexible payment mechanism linking the price the NHS pays for a medicine to the outcomes it achieves in practice for NHS…

Making Outcome-Based Payment a Reality in the NHS

2 January 2019

This report explores the feasibility of introducing one type of flexible payment mechanism – outcome-based payment (OBP) – for cancer medicines into the NHS in England. OBP could help to accelerate patient access to some new medicines and ensure close monitoring of real-world patient benefit.

Exploring the Interdependency between Public and Charitable Medical Research

1 April 2011

Continuing concern about the fiscal deficit makes it likely that government funding of health and medical research will remain under scrutiny. This OHE Consulting study, commissioned…